India News | Reported by Rishika Baruah, Sukirti Dwivedi, Edited by Anindita Sanyal | Sunday January 3, 2021
Bharat Biotech's coronavirus vaccine, which is still undergoing clinical trial, is likely to be the "back-up" vaccine in the coming days, Dr Randeep Guleria, the chief of Delhi's All-India Institute of Medical Sciences said today as two vaccines got emergency approval from the country's drug regulator. Politics has started over the approval to Cova...
www.ndtv.com